Primary lung cancer surgery after curative chemoradiotherapy for esophageal cancer patients

Kazuhiko Shien, Motohiro Yamashita, Mikio Okazaki, Hiroshi Suehisa, Shigeki Sawada, Shinichiro Miyoshi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The safety and perioperative problems of primary lung cancer surgery after curative chemoradiotherapy (CRT) for thoracic esophageal cancer (EC) are controversial. We retrospectively evaluated six patients who had received curative CRT for EC from 2003 to 2009, in whom the lung nodule was identified as a primary lung cancer and who subsequently underwent pulmonary resection. The treatment for EC consisted of chemotherapy with cisplatin and 5-fluorouracil with concurrent curative thoracic radiotherapy (60 Gy). The median age at the surgery was 75 years (range 69-80 years). The median time from radiation to pulmonary resection was 26 months (range 7-70 months). All patients had a predicted postoperative forced expiratory volume in 1 s (FEV1)% of>40% before lung surgery. The surgical difficulty 1 involves mediastinal lymph node dissection following tissue fibrotic changes after thoracic radiation. Postoperative complications occurred in two patients, and included arrhythmia and empyema. The patient who developed empyema had a massive pericardial effusion after CRT and underwent pericardial fenestration at the time of pulmonary resection. There was no operative mortality. Lung cancer surgery after curative CRT for EC is feasible in carefully evaluated and selected patients.

Original languageEnglish
Pages (from-to)1002-1006
Number of pages5
JournalInteractive Cardiovascular and Thoracic Surgery
Volume12
Issue number6
DOIs
Publication statusPublished - Jun 2011

Fingerprint

Chemoradiotherapy
Esophageal Neoplasms
Lung Neoplasms
Lung
Empyema
Thorax
Radiation
Pericardial Effusion
Forced Expiratory Volume
Lymph Node Excision
Fluorouracil
Cisplatin
Cardiac Arrhythmias
Radiotherapy
Safety
Drug Therapy
Mortality

Keywords

  • Chemoradiotherapy
  • Esophageal cancer
  • Lung cancer

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Primary lung cancer surgery after curative chemoradiotherapy for esophageal cancer patients. / Shien, Kazuhiko; Yamashita, Motohiro; Okazaki, Mikio; Suehisa, Hiroshi; Sawada, Shigeki; Miyoshi, Shinichiro.

In: Interactive Cardiovascular and Thoracic Surgery, Vol. 12, No. 6, 06.2011, p. 1002-1006.

Research output: Contribution to journalArticle

Shien, Kazuhiko ; Yamashita, Motohiro ; Okazaki, Mikio ; Suehisa, Hiroshi ; Sawada, Shigeki ; Miyoshi, Shinichiro. / Primary lung cancer surgery after curative chemoradiotherapy for esophageal cancer patients. In: Interactive Cardiovascular and Thoracic Surgery. 2011 ; Vol. 12, No. 6. pp. 1002-1006.
@article{d928ffb3d7294c3a976a966079598de0,
title = "Primary lung cancer surgery after curative chemoradiotherapy for esophageal cancer patients",
abstract = "The safety and perioperative problems of primary lung cancer surgery after curative chemoradiotherapy (CRT) for thoracic esophageal cancer (EC) are controversial. We retrospectively evaluated six patients who had received curative CRT for EC from 2003 to 2009, in whom the lung nodule was identified as a primary lung cancer and who subsequently underwent pulmonary resection. The treatment for EC consisted of chemotherapy with cisplatin and 5-fluorouracil with concurrent curative thoracic radiotherapy (60 Gy). The median age at the surgery was 75 years (range 69-80 years). The median time from radiation to pulmonary resection was 26 months (range 7-70 months). All patients had a predicted postoperative forced expiratory volume in 1 s (FEV1){\%} of>40{\%} before lung surgery. The surgical difficulty 1 involves mediastinal lymph node dissection following tissue fibrotic changes after thoracic radiation. Postoperative complications occurred in two patients, and included arrhythmia and empyema. The patient who developed empyema had a massive pericardial effusion after CRT and underwent pericardial fenestration at the time of pulmonary resection. There was no operative mortality. Lung cancer surgery after curative CRT for EC is feasible in carefully evaluated and selected patients.",
keywords = "Chemoradiotherapy, Esophageal cancer, Lung cancer",
author = "Kazuhiko Shien and Motohiro Yamashita and Mikio Okazaki and Hiroshi Suehisa and Shigeki Sawada and Shinichiro Miyoshi",
year = "2011",
month = "6",
doi = "10.1510/icvts.2010.263509",
language = "English",
volume = "12",
pages = "1002--1006",
journal = "Interactive Cardiovascular and Thoracic Surgery",
issn = "1569-9293",
publisher = "European Association for Cardio-Thoracic Surgery",
number = "6",

}

TY - JOUR

T1 - Primary lung cancer surgery after curative chemoradiotherapy for esophageal cancer patients

AU - Shien, Kazuhiko

AU - Yamashita, Motohiro

AU - Okazaki, Mikio

AU - Suehisa, Hiroshi

AU - Sawada, Shigeki

AU - Miyoshi, Shinichiro

PY - 2011/6

Y1 - 2011/6

N2 - The safety and perioperative problems of primary lung cancer surgery after curative chemoradiotherapy (CRT) for thoracic esophageal cancer (EC) are controversial. We retrospectively evaluated six patients who had received curative CRT for EC from 2003 to 2009, in whom the lung nodule was identified as a primary lung cancer and who subsequently underwent pulmonary resection. The treatment for EC consisted of chemotherapy with cisplatin and 5-fluorouracil with concurrent curative thoracic radiotherapy (60 Gy). The median age at the surgery was 75 years (range 69-80 years). The median time from radiation to pulmonary resection was 26 months (range 7-70 months). All patients had a predicted postoperative forced expiratory volume in 1 s (FEV1)% of>40% before lung surgery. The surgical difficulty 1 involves mediastinal lymph node dissection following tissue fibrotic changes after thoracic radiation. Postoperative complications occurred in two patients, and included arrhythmia and empyema. The patient who developed empyema had a massive pericardial effusion after CRT and underwent pericardial fenestration at the time of pulmonary resection. There was no operative mortality. Lung cancer surgery after curative CRT for EC is feasible in carefully evaluated and selected patients.

AB - The safety and perioperative problems of primary lung cancer surgery after curative chemoradiotherapy (CRT) for thoracic esophageal cancer (EC) are controversial. We retrospectively evaluated six patients who had received curative CRT for EC from 2003 to 2009, in whom the lung nodule was identified as a primary lung cancer and who subsequently underwent pulmonary resection. The treatment for EC consisted of chemotherapy with cisplatin and 5-fluorouracil with concurrent curative thoracic radiotherapy (60 Gy). The median age at the surgery was 75 years (range 69-80 years). The median time from radiation to pulmonary resection was 26 months (range 7-70 months). All patients had a predicted postoperative forced expiratory volume in 1 s (FEV1)% of>40% before lung surgery. The surgical difficulty 1 involves mediastinal lymph node dissection following tissue fibrotic changes after thoracic radiation. Postoperative complications occurred in two patients, and included arrhythmia and empyema. The patient who developed empyema had a massive pericardial effusion after CRT and underwent pericardial fenestration at the time of pulmonary resection. There was no operative mortality. Lung cancer surgery after curative CRT for EC is feasible in carefully evaluated and selected patients.

KW - Chemoradiotherapy

KW - Esophageal cancer

KW - Lung cancer

UR - http://www.scopus.com/inward/record.url?scp=79958716486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958716486&partnerID=8YFLogxK

U2 - 10.1510/icvts.2010.263509

DO - 10.1510/icvts.2010.263509

M3 - Article

C2 - 21441256

AN - SCOPUS:79958716486

VL - 12

SP - 1002

EP - 1006

JO - Interactive Cardiovascular and Thoracic Surgery

JF - Interactive Cardiovascular and Thoracic Surgery

SN - 1569-9293

IS - 6

ER -